Alpha Tau Medical (Alpha Tau Medical) ROCE % : -13.26% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alpha Tau Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -13.26%.

Alpha Tau Medical ROCE % Historical Data

The historical data trend for Alpha Tau Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical ROCE % Chart

Alpha Tau Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-26.52

-22.79

-61.47

-43.93

-26.90

Alpha Tau Medical Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial										-33.10	-30.53	-30.18	-34.61	-13.26

Alpha Tau Medical ROCE % Calculation

Alpha Tau Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-29.066	/	( ( (120.149 - 4.338)	+	(107.388 - 7.102) )	/ 2 )
	=	-29.066	/	( (115.811	+	100.286)	/ 2 )
	=	-29.066	/	108.0485
	=	-26.90 %

Alpha Tau Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-13.316	/	( ( (106.739 - 6.239)	+	(107.388 - 7.102) )	/ 2 )
	=	-13.316	/	( ( 100.5	+	100.286 )	/ 2 )
	=	-13.316	/	100.393
	=	-13.26 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Alpha Tau Medical (NAS:DRTS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alpha Tau Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Tau Medical (Alpha Tau Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605

Website

https://www.alphatau.com

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.